2017 Annual Meeting

Apr 5, 2017 ‐ Apr 8, 2017


Standard: $250.00

Sessions

SESSION 50: Influencing Long-term Outcomes in Lung Transplantation

Apr 8, 2017 12:00pm ‐ Apr 8, 2017 1:30pm

Identification: 050

(515) A Study of QuantiFERON-CMV-Directed CMV Prophylaxis versus Standard-of-Care to Reduce Late CMV Reactivation Following Lung Transplantation
Glen Westall, FRACP, PhD

(516) Regulation of KLRG1 Gene Expression by T-bet Correlates with Human Cytomegalovirus-Specific CD8+ T Cells Effector Function
John McDyer, MD

(517) Single Nucleotide Polymorphism in a Gene Involved in Mycophenolic Acid Metabolism Is Linked to Survival Post-Lung Transplantation
Laneshia Tague, MD

(518) Basliximab for CNI Holiday in Lung Transplant Recipients with Acute Kidney Injury
Umesh Goswami, MD

(519) Regional Variation in Lung Transplant Outcomes
William Whited, MD

(520) The Burden of Sinus Disease in Cystic Fibrosis Lung Transplant Recipients
Letizia Corinna Morlacchi

Speaker(s):

SESSION 51: Optimizing Outcomes After Heart Transplantation: Predictors and Risk Scores

Apr 8, 2017 12:00pm ‐ Apr 8, 2017 1:30pm

Identification: 051

(521) Is the ISHLT-Suggested Inotrope Score a Predictor of In-Hospital Mortality After Heart Transplantation?
Michael Salna, BMSc

(522) GIMVECH: A Novel Risk Score for Stroke in the Perioperative Post Transplant Period
Nandini Nair, MD, PhD

(523) Early Acute Humoral Rejection Does Not Alter Prognosis After Heart Transplantation
Guillaume Coutance, MD

(524) Influence of Structurally Based HLA Mismatching on Long-Term Graft Loss in Adult Heart Transplant Recipients
Johan Nilsson, MD, PhD

(525) Consequence of Retained Defibrillator and Pacemaker Leads Following Heart Transplantation - An Under-Sensed Problem?
Luise Holzhauser, MD

(526) High-Risk and Low-Risk Donor/Recipient Characteristics and 90-Day Transplant Outcomes in LVAD versus Standard Recipients
Marian Urban, MD

Speaker(s):
  • Michael Salna, BMSc, Columbia University College of Physicians and Surgeons
  • Nandini Nair, MD, PhD, Texas Tech health Sciences Center
  • Guillaume Coutance, MD, Paris Transplant Group, Pitié-Salpêtrière Hospital, Paris, France
  • Johan Nilsson, MD, PhD, Skanes University Hospital Cardiothoracic Surgery, Lund, Sweden
  • Luise Holzhauser, MD, University of Chicago, Chicago, IL, United States
  • Marian Urban, MD, PhD, Freeman Hospital
Tags: MCS PATH HTX

SESSION 52: Does Size Matter? Center Volume, Urgency Status and Managing Complications

Apr 8, 2017 12:00pm ‐ Apr 8, 2017 1:30pm

Identification: 052

(527) Benefits of Specialized Thoracic Adapted Recovery (STAR) Team Model for Heart and Lung Transplantation
Hassan Tetteh, MD, MBA

(528) Should Heart Transplantation in High Risk Recipients Be Performed in High Volume Centers?
Carine Jasseron, PhD

(529) Effect of Broader Geographic Sharing of Donor Lungs on Regional Waitlist (WL) Mortality and Transplant Center Volume
Gundeep Dhillon, MD

(530) Use of Urgent Statuses to List Adult Heart Transplant Candidates Is Increasing
William Parker, MD

(532) The Impact of Center VAD Operative Volumes on Outcomes After VAD Implant
Jennifer Cowger, MD, MS

Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content